Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets

Cases of Middle East respiratory syndrome coronavirus (MERS-CoV) continue to be identified and with a lack of effective clinical treatment and no preventative strategies, treatment using convalescent plasma or monoclonal antibodies (mAbs) is a potential quick route to an intervention. Passive immuno...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antiviral Res
Autori principali: van Doremalen, Neeltje, Falzarano, Darryl, Ying, Tianlei, de Wit, Emmie, Bushmaker, Trenton, Feldmann, Friederike, Okumura, Atsushi, Wang, Yanping, Scott, Dana P., Hanley, Patrick W., Feldmann, Heinz, Dimitrov, Dimiter S., Munster, Vincent J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Published by Elsevier B.V. 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6957253/
https://ncbi.nlm.nih.gov/pubmed/28389142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2017.03.025
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi